UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine ... and is thought to combine bronchodilator and anti ...

Once you have recovered after surgery, be sure to maintain close follow up of your pulmonary condition so that you can take medications and adopt lifestyle methods to slow the progression of your COPD ...

This includes steroid-containing combinations and long-acting bronchodilators ... to Ultibro Breezhaler from other COPD treatments, such as inhaled steroid-containing combination therapies ...

A RECENT study examining real-world COPD treatment outcomes has highlighted safety concerns regarding single-inhaler triple therapy compared to the long-acting beta2-agonist (LABA) and inhaled ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator ... pathobiology and response to medications can personalize drug ...

“Pharmaceutical companies should not be able to use reformulating as an excuse to sidestep their promises to patients.” Twenty-five million Americans with asthma and 16 million Americans with COPD ...

Mild to moderate COPD with vs without emphysema is associated with significantly worse HRQOL, but similar lung function decline.

A large variety of airway clearance devices are commercially available, the two most recent being the Quake® and the Lung Flute®. The Quake is a pipe-shaped oscillatory PEP device that bears ...

Patients diagnosed with asthma should no longer be prescribed SABA alone There are clear data that unopposed or excessive use of short acting bronchodilator agonists (SABAs) increases risk of asthma ...